NCT03471845View on ClinicalTrials.gov

RESOLUTE ONYX China Single Arm Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

591

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

February 24, 2021

Study Completion Date

October 2, 2025

Conditions
Ischemic Heart DiseaseStenotic Coronary LesionCardiovascular DiseasesArteriosclerosisCoronary Artery Disease
Interventions
DEVICE

Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System

Treatment of subjects eligible for percutaneous transluminal coronary angioplasty (PTCA) as per study requirements

Trial Locations (1)

Unknown

Affiliated Hospital of Jiangsu University, Zhenjiang

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY